[HTML][HTML] Epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an …

MD Bergamasco, CAP Pereira, C Arrais-Rodrigues… - Journal of Fungi, 2021 - mdpi.com
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal …

MD Bergamasco, CAP Pereira… - Journal of …, 2021 - search.proquest.com
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

[PDF][PDF] Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an …

MD Bergamasco, CAP Pereira, C Arrais-Rodrigues… - 2021 - pdfs.semanticscholar.org
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

Epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an antifungal …

MD Bergamasco, CAP Pereira, C Arrais-Rodrigues… - 2021 - cabidigitallibrary.org
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

[PDF][PDF] Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an …

MD Bergamasco, CAP Pereira, C Arrais-Rodrigues… - 2021 - researchgate.net
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

[HTML][HTML] Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an …

MD Bergamasco, CAP Pereira… - Journal of …, 2021 - ncbi.nlm.nih.gov
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal …

MD Bergamasco, CAP Pereira… - Journal of Fungi …, 2021 - europepmc.org
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal …

MD Bergamasco, CAP Pereira, C Arrais-Rodrigues… - 2021 - agris.fao.org
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal …

MD Bergamasco, CAP Pereira… - Journal of fungi …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with hematologic malignancies and hematopoietic cell transplant recipients (HCT)
are at high risk for invasive fungal disease (IFD). The practice of antifungal prophylaxis with …